Fritextsökning
Innehållstyper
-
Meribel Pharma Solna
-
Bio-Works
-
Danish biotech to buy struggling American oncology company
Danish drugmaker Pharmacosmos has agreed to acquire American pharmaceutical company G1 Therapeutics in a deal that amounts to 405 million dollars.
-
Metabolon
-
GSK acquires oncology research company
GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.
-
Aurevia
-
ProPharma
-
Security flaw in Swedish breast cancer screening software – woman passed away
A lack of safeguard in Sectra's software led to a woman with breast cancer receiving an incorrect diagnosis. She later passed away. The software is used in 20 o...
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
ZEISS Metrology Shop provides planning security
ZEISS Metrology Shop brings it all together.
-
Webinar: Support Trial Patients Transitioning to the Commercial Space
Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.
-
Cost-efficient development of laboratory devices
8 ways to optimise development costs and speed up processes
-
Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”
”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...
-
WuXi AppTec, UK Ltd
-
Öppen frågestund: Regulatory Opportunities for Rare Diseases/Orphan Products in US and EU
Anmäl dig till vår nästa session av Office Hours den 28 februari klockan 15:00 (svensk tid), en öppen frågestund om utveckling av särläkemedel (orphan drugs).
-
Unmatched performance and flexibility in its class
The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.
-
Positive trend for Swedish medtech exports – “We have new markets that are huge”
In 2024, Swedish exports of pharmaceuticals decreased for the first time in several years. However, the trend for medical technology looks brighter. During a se...
-
Joy at Egetis after positive CHMP opinion – ”The single most important milestone”
Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."
-
Pharma Outsourcing – Find the Right Partner (2026)
-
16 miljoner kronor till ATMP i Västsverige
Genom en miljonsatsning i Västra Götalandsregionen ska små och medelstora life sciene-bolag få stöd för att accelerera utvecklingen inom avancerade terapiläkemedel (ATMP).
-
Revealing the secrets of a part
CT inspection in automation technology at Festo.
-
Swedish and Ukrainian Medical Product Agencies sign an agreement
The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.
-
“Don’t postpone the transition to IVDR”
Operators who have not yet started to adapt to the requirements of the new EU IVDR regulation are running out of excuses. This is the opinion of Helena Dzojic, ...
-
Tio life science-projekt får miljonanslag – ny utlysning öppnar
En rad life science-projekt har fått miljonanslag i ett svenskt proof of concept-program. 13 januari öppnar en ny utlysning.